Search Results - "Avon, Christopher"
-
1
-
2
Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir
Published in Journal of pharmaceutical sciences (01-02-2016)“…The objective was to assess the impact of larger than conventional amounts of 14 commonly used excipients on Biopharmaceutics Classification System (BCS) class…”
Get more information
Journal Article -
3
Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys
Published in The Journal of clinical investigation (01-04-2010)“…Chronic rejection currently limits the long-term efficacy of clinical transplantation. Although B cells have recently been shown to play a pivotal role in the…”
Get full text
Journal Article -
4
Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys
Published in Transplantation (01-01-2017)“…BACKGROUNDAnti-CD154 monotherapy is associated with antidonor allo-antibody (Ab) elaboration, cardiac allograft vasculopathy (CAV), and allograft failure in…”
Get full text
Journal Article -
5
Reply to "On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs"
Published in Journal of pharmaceutical sciences (01-04-2016)“…We previously concluded that 12 common excipients need not be qualitatively the same and quantitatively very similar to reference for Biopharmaceutics…”
Get more information
Journal Article -
6
Preemptive CD20^sup +^ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys
Published in The Journal of clinical investigation (01-04-2010)“…Chronic rejection currently limits the long-term efficacy of clinical transplantation. Although B cells have recently been shown to play a pivotal role in the…”
Get full text
Journal Article -
7
Preemptive [CD20.sup.+] B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys
Published in The Journal of clinical investigation (01-04-2010)“…Chronic rejection currently limits the long-term efficacy of clinical transplantation. Although B cells have recently been shown to play a pivotal role in the…”
Get full text
Journal Article